Strober , B.; Asahina, A.; Mrowietz, U.; Lebwohl, M.; Foley, P.; Langley, R.; Barker, J.; Cioffi, C.; Cross, N.; Wang, M. .; Paul, C. Bimekizumab Response Maintenance through Two Years of Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Responded After 16 Weeks: Interim Results from the BE BRIGHT Open-Label Extension Trial. J of Skin 2021, 5, s52.